Geron Corporation

RYTELO

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

Geron Corporation

RYTELO HCPCS:

Miscellaneous HCPCS

HCPCS Code Descriptor:

No HCPCS Assigned

Category:

Miscellaneous HCPCS

RYTELO NDCs:

82959-0111-01, 82959-0112-01

Primary Type:

Hematology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

RYTELO CPT Codes:

96413 - Intravenous infusion up to 60 minutes, single or initial substance/drug

96415 - 61 minutes or more (use with 96413)

Some of the most common CPT administration codes for 'buy and bill' drugs can be found at the following link:

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About RYTELO:

RYTELO is a hematology drug manufactured by Geron and administered via the intravenous route of administration. RYTELO has not yet received a HCPCS code

ACCESS PRICING AND MORE BY REGISTERING

HCPCS Added Date:

Not Available

HCPCS Effective Date:

Not Available

HCPCS Termination Date:

Not Available

Billing and coding information for RYTELO can be found through Geron.
RYTELO patient assistance information can be found through Geron.
RYTELO prescribing information can be found at the link below:
Information regarding RYTELO’s side effects can be found at MedlinePlus

BuyandBill.com Drug Alert: